Delivery Order SPE2DB20D1100-SPE2DB25FE1EJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 tablets. This contract is a firm fixed price delivery order with a ceiling value of $1,436.91 and an ultimate completion date of September 3, 2025. The award carries no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,819.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100-count units). This is a non-set-aside contract with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,441.00 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be completed by September 11, 2025, at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units, with a contract ceiling value of $3,857.54. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The work will be performed at the...
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.58 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,518.01 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 15 mg tablets (100-count units) with a ceiling value of $1,696.75. The contract is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and was awarded on September 24, 2025, with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.42 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1EJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,169.04 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 26, 2025, and represents performance at the awardee's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. The IDC serves as a prime vendor contract enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Through this contract vehicle, the company supports critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, providing both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/25/25 |